Public annual accounts

Pharmaconsult financials

Name: Pharmaconsult financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Pharmaconsult, with comparable measures and links to available source documents.

Company overview

Registry number

0508581589

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for Pharmaconsult

2025 versus 2024

Operating line: €75,930
EBITDA: €75,310
Total assets: €669,769
Equity: €286,815

EBITDA margin +99.2% · Equity ratio +42.8%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Sept 2025	€75,930	€75,310	€669,769	€286,815	-
202430 Sept 2024	€79,763	€72,674	€670,858	€280,972	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report